New Fixed-Dose Artesunate-Mefloquine Formulation Against Multidrug-Resistant Plasmodium Falciparum in Adults: A Comparative Phase IIb Safety and Pharmacokinetic Study With Standard-Dose Nonfixed Artesunate Plus Mefloquine

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.01187-09